Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.
Millions of homes just became eligible for solar power.
Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.
Estuary Biotherapeutics is a biotechnology company developing genetic medicines for serious kidney diseases.
MMI is a medical technology company that develops robotic systems for microsurgery and supermicrosurgery.
Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.
Pyxis Oncology is a biotechnology firm that develops antibody therapeutics intended to promote the body's immune response to cancer.
AN2 Therapeutics develops small-molecule medicines from boron chemistry for infectious diseases, hematologic disorders, and oncology.
Navigator Medicines operate as a biotech company.
Circle Pharma is a biotechnology company creating bioavailable macrocyclic peptide therapeutics that target protein-protein interactions.
Planted is a solar deployment technology company that uses AI powered robots and software to plan and deploy solar projects.
Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.
Solstice Oncology develops immuno-oncology therapies focused on treating and preventing cancer through targeted approaches.
Tectora Therapeutics is a biotechnology company developing oral medicines for immune-mediated diseases.
Helus Pharma is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.
Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.
Superluminal Medicines develops small-molecule therapeutics using AI, biology, and chemistry.
Typewriter Therapeutics develops mRNA-based gene therapies using a gene writing platform for site-specific insertion of therapeutic genes.
AusperBio is a biotechnology company focused on developing oligonucleotide therapeutics and targeted delivery technologies.
Expedition Therapeutics develops treatments for COPD and other inflammatory respiratory diseases.
SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.
Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.
Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.
RA Capital Management has invested in 467 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
RA Capital Management's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 23 different industry categories.
Among tracked funding rounds, Vaxcyte received $575.0M in a Post-IPO Debt round. RA Capital Management's total known invested capital is $56.7B.
RA Capital Management's average investment size is $123.5M across its portfolio of 467 companies.
Recent RA Capital Management portfolio additions include Aclaris Therapeutics, Star Therapeutics, Optivolt, Adela, Estuary Biotherapeutics. These companies were founded in 2020 or later.